News | Advanced Visualization | November 15, 2017

Arterys Completes Series B to Accelerate Product Commercialization

Company will use funding to expand web-based artificial intelligence platform, launch new imaging analytics products in oncology and neurology

Arterys Completes Series B to Accelerate Product Commercialization

November 15, 2017 — Arterys Inc. announced the close of its $30M Series B financing round. The investment was led by Temasek, with strategic investors Northwell Health Ventures, NewYork-Presbyterian, Varian Medical Systems and GE Ventures, and joined by Fosun, DNA Capital, Emergent Medical Partners and ORI Capital. Arterys plans to use the funding to expand its web-based artificial intelligence (AI) platform, and launch several products in oncology and neurology, and to accelerate the commercialization of its cardiac imaging offering. This new round will enable more radiologists to benefit from artificial intelligence in their daily work.

Arterys has created a novel AI platform for medical image analytics. Contrary to the current solutions that are installed inside hospitals, Arterys software is web-based. As a result, physicians benefit from vast amounts of computation, which is necessary to run artificial intelligence algorithms in a timely manner. Physicians can now process their patient cases with support from AI algorithms that are embedded in their workflow. This is possible thanks to proprietary technology that protects patient information and complies with data privacy regulations in the United States and European Union.

"We were impressed with the Arterys approach, fusing the latest cloud and artificial intelligence technologies with a true user-centric design methodology. This results in augmented workflows with increased efficiency and consistency, while the radiologist remains in charge of the final clinical decision," said Thomas Thornton, senior vice president of Northwell Health Ventures.

The Arterys cloud platform supports a variety of imaging modalities, such as magnetic resonance imaging (MRI) and computed tomography (CT). It provides a solid foundation for seamless image interpretation with artificial intelligence tools, case sharing and automated reporting. The platform is designed to capture user edits on the results of the machine learning, so that algorithms can be improved based on real-world use. Working together, these capabilities enable the company to quickly build and commercialize new product offerings.

Arterys started with cardiac MRI, one of the most complex and time consuming workflows, to demonstrate the power of a combined artificial intelligence and cloud computing approach. It was the first product its kind to obtain U.S. Food and Drug Administration (FDA) clearance for use as a diagnostic support tool, and is also cleared in Canada and the EU. The software has significant benefits for patients and clinicians, reducing the time the patient needs to be in the scanner, and automating key clinical measurements for the radiologist.

For more information: www.arterys.com

Related Content

Artificial Intelligence Provides Faster, Clearer MRI Scans

A new artificial-intelligence-based approach to image reconstruction, called AUTOMAP, yields higher quality images from less data, reducing radiation doses for CT and PET and shortening scan times for MRI. Shown here are MR images reconstructed from the same data with conventional approaches, at left, and AUTOMAP, at right. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital

News | Artificial Intelligence | July 17, 2018
A research team with funding from the National Institute for Biomedical Imaging and Bioengineering (NIBIB) has...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
Guerbet, IBM Watson Health Partner on Artificial Intelligence for Liver Imaging
News | Clinical Decision Support | July 10, 2018
Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an...
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
3-D Imaging and Computer Modeling Capture Breast Duct Development

An image of a developing mammary duct. Image courtesy of Andrew Ewald.

News | Breast Imaging | June 28, 2018
A team of biologists has joined up with civil engineers to create what is believed to be the first 3-D computer model...
EchoMD AutoEF Software Improves Variability in Ejection Fraction Estimation
News | Cardiovascular Ultrasound | June 27, 2018
A recent study conducted with the Minneapolis Heart Institute found that Bay Labs’ EchoMD AutoEF deep learning software...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
Overlay Init